
Demonstrated a new beneficial effect of bempedoic acid in an experimental rat model of non-alcoholic fatty liver disease. This drug has been approved for use in humans for the treatment of hypercholesterolemia
A study led by the IBUB team of Juan C. Laguna, Professor of Pharmacology at Universitat de Barcelona, demonstrates a new beneficial effect of bempedoic acid in an experimental model of rats with non-alcoholic fatty liver disease. This drug has been approved for use in humans in the treatment of hypercholesterolemia. The pathology of non-alcoholic